Results 191 to 200 of about 44,745 (290)

Immune Response to Bioluminescence Imaging Reporters in Murine Tumor Models. [PDF]

Mol Imaging Biol
Basnet A, Thomas DD, Landreth KM, Damron FH, Liu TW.   +4 more
europepmc   +1 more source

In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin. [PDF]

Cell Chem Biol, 2023
Gonciarz RL, Jiang H, Tram L, Hugelshofer CL, Ekpenyong O, Knemeyer I, Aron AT, Chang CJ, Flygare JA, Collisson EA, Renslo AR.   +10 more
europepmc   +1 more source

An optimized luciferin formulation for NanoLuc-based in vivo bioluminescence imaging. [PDF]

Sci Rep
Gao C, Wu Y, Fitzgerald C, Wang H, Ugo T, Uyeda T, Zhou W, Su Y, Kirkland TA, Lin MZ.   +9 more
europepmc   +1 more source

S-Series Coelenterazine-Driven Combinatorial Bioluminescence Imaging Systems for Mammalian Cells. [PDF]

Int J Mol Sci, 2023
Kamiya G, Kitada N, Furuta T, Hirano T, Maki SA, Kim SB.   +5 more
europepmc   +1 more source

A telescopic microscope equipped with a quanta image sensor for live-cell bioluminescence imaging. [PDF]

Nat Methods
Ma R, Santino LM, Chobola T, Armbrust N, Geilenkeuser J, Sukumaran S, Jing Z, Levkina A, Ridderbeek K, Peng T, Truong DJ, Doll S, Westmeyer GG, Cui J.   +13 more
europepmc   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

Enhanced bioluminescence imaging of tumor cells surviving chemotherapy in a murine model of triple-negative breast cancer. [PDF]

NPJ Breast Cancer
Steinbauer S, Cowles JD, Sabbaghi MA, Poppelaars M, Hussain A, Wagesreither M, Laimer-Gruber D, Tovari J, Szakacs G, Csiszar A.   +9 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

De novo luciferases enable multiplexed bioluminescence imaging. [PDF]

Chem
Yi-Hsuan Chen J, Shi Q, Peng X, de Dieu Habimana J, Wang J, Sobolewski W, Hsien-Wei Yeh A.   +6 more
europepmc   +1 more source

In vivo bioluminescence imaging of natural bacteria within deep tissues via ATP-binding cassette sugar transporter. [PDF]

Nat Commun, 2023
Zhang Q, Song B, Xu Y, Yang Y, Ji J, Cao W, Lu J, Ding J, Cao H, Chu B, Hong J, Wang H, He Y.   +12 more
europepmc   +1 more source